The bio-impedance technique provides a safe, low-cost and non-invasive alternative for lung fluid level monitoring. Here we have investigated the feasibility of a novel bio-impedance system in measuring pulmonary congestion in elderly patients suffering from congestive heart failure (CHF). The system employed a parametric reconstruction algorithm to assess mean lung resistivity. Fourteen patients were studied before and following treatment to reduce lung congestion. Significant correlation was found between the changes of radiographic scores and resistivity values following treatment (R=0.57, p<0.04). A significant difference in resistivity values between patients having low and high congestion degrees was also demonstrated (p<0.01). Moreover, the bio-impedance technique successfully diagnosed an improvement of congestion level in 10 out of 14 patients, while the radiographic score indicated such an improvement in only 5 out of the 14 patients. These results, along with our previous validation studies, suggest that the bio-impedance technique is a feasible bedside system for monitoring of pulmonary congested patients, thus facilitating effective treatment strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.medengphy.2009.05.008 | DOI Listing |
Sleep
January 2025
Santa Barbara Actuaries Inc., Santa Barbara, CA, USA.
Study Objectives: To determine the association between adherence to positive airway pressure and healthcare costs among a national sample of older adults with comorbid OSA and common chronic conditions.
Methods: Our data source was a random sample of Medicare administrative claims for years 2016-2019. Inclusion criteria included age >65 years and new diagnosis of OSA.
Heart Rhythm O2
December 2024
Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.
Background: Atrial fibrillation (AF) is the most common arrhythmia worldwide. Data regarding 30-day readmission following index admission for AF in the developing world are poorly described.
Objectives: The study aimed to assess the rate, predictors, and trends of 30-day readmission after index admission for AF in Syria.
J Mol Cell Cardiol Plus
March 2025
Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
We previously reported that plasmalogens, a class of phospholipids, were decreased in a setting of dilated cardiomyopathy (DCM). Plasmalogen levels can be modulated via a dietary supplement called alkylglycerols (AG) which has demonstrated benefits in some disease settings. However, its therapeutic potential in DCM remained unknown.
View Article and Find Full Text PDFEur Heart J Case Rep
January 2025
Department of Cardiology, York Hospital, WellSpan Health, 30 Monument Rd, York, PA 17403, USA.
Background: ROS1 tyrosine kinase inhibitors are one of the primary immunotherapies for fusion-positive cancers. Tyrosine kinase inhibitors have markedly improved outcomes for advanced cancers previously with poor prognosis. Entrectinib is an example of an ROS1 inhibitor that can be used for lung adenocarcinoma.
View Article and Find Full Text PDFDiagnostics (Basel)
December 2024
Cardiovascular Diseases Unit, Cardio Thoracic and Vascular Department, Le Scotte Hospital, University of Siena, 53100 Siena, Italy.
Pulmonary congestion is a critical factor influencing the clinical presentation, therapeutic decisions, and outcomes of heart failure (HF) patients. Lung ultrasound (LUS) offers a simple, rapid, and accurate method for assessing pulmonary congestion, surpassing the diagnostic capabilities of traditional clinical evaluation and chest radiography. Due to the wide availability of ultrasound equipment, congestion can be evaluated in multiple settings, ranging from emergency departments to intensive care units, including outpatient settings.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!